Psychemedics Corporation
PMDI
$2.30
$0.000.00%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 74.51% | -13.91% | -79.17% | -37.35% | -2,063.92% |
| Total Depreciation and Amortization | -33.87% | -4.60% | -22.83% | -13.16% | -17.17% |
| Total Amortization of Deferred Charges | -- | -- | -- | -38.37% | -- |
| Total Other Non-Cash Items | -85.82% | 198.63% | 1,550.00% | -26.30% | 275.34% |
| Change in Net Operating Assets | 108.50% | 99.37% | -10.47% | -48.43% | -148.11% |
| Cash from Operations | 127.45% | 112.51% | -110.22% | -65.05% | -141.05% |
| Capital Expenditure | 93.18% | -- | -- | -4.72% | -72.55% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -82.22% | 206.25% | 109.43% | 28.97% | 195.74% |
| Cash from Investing | 104.65% | 156.25% | 106.85% | 125.00% | 56.12% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -297.30% | -81.08% | -4.17% | 47.52% | 57.47% |
| Issuance of Common Stock | -- | -- | -- | -75.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | 100.00% | 100.00% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -297.30% | 85.56% | -4.17% | 87.46% | 86.97% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 97.30% | 100.67% | -46.76% | -54.02% | -164.45% |
